Tag Archives: HLS

GMP FirstEnergy Maintains a Buy Rating on HLS Therapeutics Inc (HLS)

In a new note to investors on August 9, an analyst has provided a rating update for HLS Therapeutics Inc (HLS – Research Report). The Healthcare company, HLS Therapeutics Inc (TSX: HLS) has received a rating update from a Wall

SunTrust Robinson Believes Healthsouth Corp (NYSE: HLS) Won’t Stop Here

In a report issued on December 20, David S Macdonald from SunTrust Robinson reiterated a Buy rating on Healthsouth Corp (NYSE: HLS), with a price target of $58. The company’s shares closed yesterday at $49.24, close to its 52-week high

Analysts Offer Insights on Services Companies: Healthsouth Corp (NYSE: HLS), GMS Inc (NYSE: GMS) and American Eagle (NYSE: AEO)

There’s a lot to be optimistic about in the Services sector as 3 analysts just weighed in on Healthsouth Corp (NYSE: HLS), GMS Inc (NYSE: GMS) and American Eagle (NYSE: AEO) with bullish sentiments. Healthsouth Corp (NYSE: HLS) RBC Capital

Healthsouth Corp Receives a Hold from Piper Jaffray

In a report issued on September 13, Sarah James from Piper Jaffray reiterated a Hold rating on Healthsouth Corp (NYSE: HLS), with a price target of $50. The company’s shares closed on Friday at $44.94. According to TipRanks.com, James is

RBC Capital Sticks to Its Buy Rating for Healthsouth Corp

RBC Capital analyst Frank Morgan reiterated a Buy rating on Healthsouth Corp (NYSE: HLS) on September 4 and set a price target of $55. The company’s shares opened today at $45.58. According to TipRanks.com, Morgan is a 5-star analyst with

Piper Jaffray Remains a Hold on Healthsouth Corp

Piper Jaffray analyst Sarah James reiterated a Hold rating on Healthsouth Corp (NYSE: HLS) on July 31 and set a price target of $50. The company’s shares opened today at $42.50. According to TipRanks.com, James is a 5-star analyst with